Associated Retinal Consultants, Royal Oak, MI, United States; Scheie Eye Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Department of Ophthalmology, Cairo University, Cairo, Egypt; Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami, Miami, FL, United States.
Surv Ophthalmol. 2025 Jan-Feb;70(1):54-62. doi: 10.1016/j.survophthal.2024.09.009. Epub 2024 Oct 3.
Suprachoroidal hemorrhage (SCH) is a potentially visually devastating complication of intraocular surgery, but estimates of perioperative SCH incidence vary. We performed a systematic review and meta-analysis of perioperative SCH incidence among population-based studies published between 1990 and 2023. Thirty-five studies collectively reported 1657 cases of perioperative SCH from a population of 3,028,911 surgeries. The estimated incidence of SCH was 0.12 % (95 % CI, 0.10-0.14 %), or about 1 in every 800 surgeries. The estimated incidence of perioperative massive SCH was 0.06 % (95 % CI, 0.04-0.08 %). In multivariable meta-regression, greater SCH incidence was significantly associated with smaller study population size, comparative study design, multicenter study setting, and intraoperative or delayed SCH timing (vs intraoperative alone), while lower SCH incidence was significantly associated with vitreoretinal or mixed surgery type (vs. cataract) (all P < 0.05). Study year was not a significant predictor of SCH incidence, suggesting that the incidence of SCH has not decreased over the past 3 decades despite improvements in surgical technologies and techniques. Given the rarity of SCH, and the strong effect of study population size on reported SCH incidence rates, future studies of SCH incidence should include a minimum population size of at least 1000 surgeries to obtain an accurate estimate of SCH incidence.
脉络膜上腔出血 (SCH) 是眼内手术潜在的致盲性并发症,但围手术期 SCH 发生率的估计值差异很大。我们对 1990 年至 2023 年期间发表的基于人群的研究进行了系统回顾和荟萃分析,以评估围手术期 SCH 发生率。35 项研究共报告了 1657 例围手术期 SCH 病例,来自 3028911 例手术的人群。SCH 的估计发生率为 0.12%(95%CI,0.10-0.14%),即每 800 例手术中约有 1 例。围手术期大量 SCH 的估计发生率为 0.06%(95%CI,0.04-0.08%)。在多变量荟萃回归中,较大的 SCH 发生率与较小的研究人群规模、对照研究设计、多中心研究环境以及术中或延迟 SCH 时间(而非仅术中)显著相关,而较低的 SCH 发生率与玻璃体视网膜或混合手术类型(而非白内障)显著相关(均 P < 0.05)。研究年份不是 SCH 发生率的显著预测因素,这表明尽管手术技术和技术有所改进,但在过去 30 年中,SCH 的发生率并未降低。鉴于 SCH 的罕见性,以及研究人群规模对报告的 SCH 发生率的强烈影响,未来的 SCH 发生率研究应包括至少 1000 例手术的最小人群规模,以准确估计 SCH 发生率。